about
Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics ApproachThe multifaceted nature of retinoid transport and metabolismIs retinol binding protein 4 a link between adiposity and cancer?Vitamin A metabolism and adipose tissue biologyIdentification and Characterization of a Non-retinoid Ligand for Retinol-binding Protein 4 Which Lowers Serum Retinol-binding Protein 4 Levels in VivoEndocrine and Metabolic Effects of Adipose Tissue in Children and AdolescentsAssociation of serum retinol binding protein 4 with atherogenic dyslipidemia in morbid obese patientsLower fetuin-A, retinol binding protein 4 and several metabolites after gastric bypass compared to sleeve gastrectomy in patients with type 2 diabetes.Serum retinol-binding protein 4 levels are elevated but do not contribute to insulin resistance in newly diagnosed Chinese hypertensive patients.Association of plasma retinol-binding protein 4, adiponectin, and high molecular weight adiponectin with insulin resistance in non-diabetic hypertensive patientsLMNA mutations, skeletal muscle lipid metabolism, and insulin resistanceIdentification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation.Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.Plasma Protein Biomarkers Correlated with the Development of Diet-Induced Type 2 Diabetes in Mice.Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver diseaseRetinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss.Retinol-binding protein 4 (RBP4) protein expression is increased in omental adipose tissue of severely obese patients.Plasma concentrations of retinol in obese children and adolescents: relationship to metabolic syndrome components.Serum adipocyte fatty acid-binding protein, retinol-binding protein 4, and adiponectin concentrations in relation to the development of the metabolic syndrome in Korean boys: a 3-y prospective cohort study.Vitamin A metabolism: an update.Protein glycation in diabetes as determined by mass spectrometry.Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.Association of serum retinol binding protein 4 with adiposity and pubertal development in Korean children and adolescents.A polymorphism in the retinol binding protein 4 gene is not associated with gestational diabetes mellitus in several different ethnic groups.Adipokines as possible new predictors of cardiovascular diseases: a case control study.Transcriptomic identification of ADH1B as a novel candidate gene for obesity and insulin resistance in human adipose tissue in Mexican Americans from the Veterans Administration Genetic Epidemiology Study (VAGES)Vitamin A as a key regulator of obesity & its associated disorders: Evidences from an obese rat model.Effects of Aerobic Exercise on Serum Retinol Binding Protein4, Insulin Resistance and Blood Lipids in Obese Women.The Roles of Vitamin A in the Regulation of Carbohydrate, Lipid, and Protein Metabolism.Study of Omentin1 and Other Adipokines and Hormones in PCOS Patients.Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns.Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus.Adipokines and the blood-brain barrierLongitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery.Serum antioxidant concentrations and metabolic syndrome are associated among U.S. adolescents in recent national surveys.Elevated Serum Levels of Retinol-Binding Protein 4 Are Associated with Breast Cancer Risk: A Case-Control StudyAssociations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study.Retinol binding protein 4 correlates with and is an early predictor of carotid atherosclerosis in type 2 diabetes mellitus patients.Obesity and lipodystrophy--where do the circles intersect?Retinol as a cofactor for PKCδ-mediated impairment of insulin sensitivity in a mouse model of diet-induced obesity
P2860
Q26753043-14ADB420-000D-4E0B-905C-BA754EEE04D1Q26824015-ACABDD81-8327-4798-BC94-287F7B7A8299Q26862707-A89FC469-25B6-400F-A8AB-537CC05ABC31Q27001208-794D3898-B599-436A-8352-B4E6EAC106D0Q27653437-A1AECDC1-E9F9-4F12-AD12-D94CA5FBABEEQ28082438-757F924B-C18E-45CC-91FE-30A238736CB9Q28534795-A7257C4A-1612-46D2-AE11-94E8FA315572Q33573178-000A8DC8-1171-4261-9497-A37325628039Q33756947-7A05386B-5EB9-461D-B4BE-D2BF04F3CFAEQ33781951-C5A5A5AD-3D77-4C8E-B29A-1D905B512504Q33786875-4648036E-31BC-4D96-8A14-FB39C9BA94B7Q33812357-D282FD84-6C43-432B-9B45-C3C5B507E30DQ33946318-6D67419B-2095-440D-A373-76FD845ACD64Q33973509-557CA755-32A8-4B29-B634-D1E9CFA280F6Q33990346-CF8759DF-EA59-4D41-A0F9-C8404580179BQ34013478-12A74A4B-C417-4379-AB6C-BDACEEF5FABCQ34058733-8ED21E82-4E69-4540-B7EE-45ADCD9EC7B8Q34279366-703C7E9B-D4CC-4844-9B58-BC25D04FB5DDQ34404214-8CD84A8B-D3C9-41A9-971E-035CF7DDCC98Q34591540-AC7F8D62-0697-4D51-A98E-BCCAF13E797BQ34661579-F6516A31-50CF-4318-ACE9-CB671A64F9D8Q34779049-10011EC6-F7CD-4EB2-B357-4EB2AE01E9B3Q35009872-0E088386-F8B9-4E1B-810C-A7D8F9308B4FQ35171496-2EDC36ED-2C26-408C-997B-E3AC51E9A0E9Q35176565-0D44CDAE-9854-4CD4-9467-3173F21435B4Q35242951-08C23AEB-F2A7-4627-B5DC-5BF87B694546Q35640848-148B4D16-5F35-4296-B2D8-AABF24B4C0FBQ35666355-49305898-95A4-4D1C-B5B7-4F18BC724C29Q35667292-A7BB8FDB-8856-4024-89E0-4088BA207B25Q35740949-6F6D40E8-4AFD-4E71-A6B0-8C7ECE1119A9Q35829203-E9F450B1-50F0-4FD0-AC83-47B5B456B521Q35895869-BBE9C11F-EF48-4C31-86D1-50F61D0CC7B7Q36088883-FA154198-0ADC-4914-99AA-395E2D3D50D4Q36148290-2751F471-2F43-408C-8506-4AA8C3FE11C0Q36160323-287CF2C3-EB98-48D8-A982-CFECD794BE59Q36230381-A5E92251-C5A8-489C-8C6F-C44F079475F7Q36288910-171B493A-52DF-4F81-996F-1EF757ACA674Q36325541-9D98FF80-3BF7-43CA-93DE-E35A35C9CCD0Q36509769-AB77478D-4AB3-4F57-A6FB-1BC8CE447D9DQ36570962-C65C7B9E-7A2B-4C00-A972-FC0FF3C207BB
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Retinol-binding protein 4 in human obesity
@ast
Retinol-binding protein 4 in human obesity
@en
Retinol-binding protein 4 in human obesity
@en-gb
Retinol-binding protein 4 in human obesity
@nl
type
label
Retinol-binding protein 4 in human obesity
@ast
Retinol-binding protein 4 in human obesity
@en
Retinol-binding protein 4 in human obesity
@en-gb
Retinol-binding protein 4 in human obesity
@nl
prefLabel
Retinol-binding protein 4 in human obesity
@ast
Retinol-binding protein 4 in human obesity
@en
Retinol-binding protein 4 in human obesity
@en-gb
Retinol-binding protein 4 in human obesity
@nl
P2093
P921
P356
P1433
P1476
Retinol-binding protein 4 in human obesity
@en
P2093
Arya M Sharma
Frauke Adams
Jana Böhnke
Jens Jordan
Jürgen Janke
Stefan Engeli
P304
P356
10.2337/DB06-0616
P407
P577
2006-10-01T00:00:00Z